Oncology News

Patients with HIV, hepatitis C and cirrhosis may be at a higher risk for hepatocellular carcinoma if they are resistant to insulin, according to a recent study.

Levels of hepatitis B surface antigen can help to predict the risk of hepatocellular carcinoma in certain patients, according to recent results.

A high-dose targeted oncolytic poxvirus, dubbed JX-594, increased survival rates in patients with advanced, previously treated hepatocellular carcinonma, according to phase 2 trial results presented during the Annual Meeting of the American Association for the Study of Liver Diseases.

Non-alcoholic fatty liver disease was found in a study to not be associated with an increased risk of death.

SAN FRANCISCO — It is more likely that older adults will die from cancer or cardiovascular disease than liver-related causes, Jeoffrey Schouten, MD, said during a presentation here at The Liver Meeting.

Histological abnormalities were identified in noncancerous hepatic tissues of hepatocellular carcinoma patients after hepatitis C virus eradication, indicating hepatocarcinogenesis, according to findings presented at The Liver Meeting, the 2011 Annual Meeting of the American Association for the Study of Liver Diseases.

The following is some of the research presented at the initial session of the American Association for the Study of Liver Diseases’ 2011 Liver Meeting in San Francisco:

Patients with metabolic syndrome had a twofold higher risk for hepatocellular carcinoma and a 1.56-fold increased risk for intrahepatic cholangiocarcinoma, according to results of a new study.

Post-transplantation metabolic syndrome occurs in more than half of liver transplant recipients, placing them at higher risk for cardiovascular disease, according to researchers.

The proportion of progression events in patients treated with doxorubicin/sorafenib combination therapy was half that of patients treated with doxorubicin and placebo, according to study results.